Skip to main content
NCBI home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1978 Feb;13(2):266–270. doi: 10.1128/aac.13.2.266

Synergistic Action of Amphotericin B and Antioxidants Against Certain Opportunistic Yeast Pathogens

William H Beggs 1, Fred A Andrews 1, George A Sarosi 1
PMCID: PMC352225  PMID: 348098

Abstract

Results of earlier turbidimetric growth experiments showed that certain antioxidants prolonged the antifungal activity of amphotericin B (AB) against Candida albicans, presumably by retarding autoxidative destruction of the drug. Viability studies were designed to examine this in more detail. Subinhibitory concentrations of either butylated hydroxyanisole, n-propyl gallate, or nordihydroguaiaretic acid in combination with fungistatic levels of AB exerted synergistic fungicidal activity against two strains of C. albicans and one of C. parapsilosis. Although synergism was not seen in tests with a strain of Torulopsis glabrata, antioxidants prolonged the inhibitory action of AB against this organism. On the basis of these findings and other considerations that are discussed, it is suggested that stabilization of AB and the ability to act synergistically with AB represent two distinctly different effects of the antioxidants.

Full text

PDF
266

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Andrews F. A., Beggs W. H., Sarosi G. A. Influence of antioxidants on the bioactivity of amphotericin B. Antimicrob Agents Chemother. 1977 Apr;11(4):615–618. doi: 10.1128/aac.11.4.615. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Hamilton-Miller J. M. Chemistry and biology of the polyene macrolide antibiotics. Bacteriol Rev. 1973 Jun;37(2):166–196. [PMC free article] [PubMed] [Google Scholar]
  3. Hamilton J. D., Elliott D. M. Combined activity of amphotericin B and 5-fluorocytosine against Cryptococcus neoformans in vitro and in vivo in mice. J Infect Dis. 1975 Feb;131(2):129–137. doi: 10.1093/infdis/131.2.129. [DOI] [PubMed] [Google Scholar]
  4. Jawetz E. The use of combinations of antimicrobial drugs. Annu Rev Pharmacol. 1968;8:151–170. doi: 10.1146/annurev.pa.08.040168.001055. [DOI] [PubMed] [Google Scholar]
  5. Kwan C. N., Medoff G., Kobayashi G. S., Schlessinger D., Raskas H. J. Potentiation of the antifungal effects of antibiotics by amphotericin B. Antimicrob Agents Chemother. 1972 Aug;2(2):61–65. doi: 10.1128/aac.2.2.61. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Medoff G., Comfort M., Kobayashi G. S. Synergistic action of amphotericin B and 5-fluorocytosine against yeast-like organisms. Proc Soc Exp Biol Med. 1971 Nov;138(2):571–574. doi: 10.3181/00379727-138-35943. [DOI] [PubMed] [Google Scholar]
  7. Rickards R. W., Smith R. M., Golding B. T. Macrolide antibiotic studies. XV. The autoxidation of the polyenes of the filipin complex and lagosin. J Antibiot (Tokyo) 1970 Dec;23(12):603–612. [PubMed] [Google Scholar]
  8. TINGSTAD J. E., GARRETT E. R. Studies on the stability of filipon. I. Thermal degradation in the presence of air. J Am Pharm Assoc Am Pharm Assoc. 1960 Jun;49:352–355. [PubMed] [Google Scholar]
  9. Ward M. S., Ward B. Q. Initial evaluation of the effect of butylated hydroxytoulene upon Salmonella senftenberg 775W. Poult Sci. 1967 Nov;46(6):1601–1603. doi: 10.3382/ps.0461601. [DOI] [PubMed] [Google Scholar]
  10. Yang C. S., Strickhart F. S. Inhibition of hepatic mixed function oxidase activity by propyl gallate. Biochem Pharmacol. 1974 Nov 15;23(22):3129–3138. doi: 10.1016/0006-2952(74)90598-x. [DOI] [PubMed] [Google Scholar]
  11. Yang C. S., Strickhart F. S., Woo G. K. Inhibition of the mono-oxygenase system by butylated hydroxyanisole and butylated hydroxytoluene. Life Sci. 1974 Oct 15;15(8):1497–1505. doi: 10.1016/0024-3205(74)90124-6. [DOI] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES